Comparative study between the creams Ozenoxacin and Nadifloxacin in facial Acne
Phase 2
- Registration Number
- CTRI/2024/01/061760
- Lead Sponsor
- ENDLURU SASIKALA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Acne grades 1,2,3
At least 10 lesions
Agreed to sign consent
Exclusion Criteria
Usage of topical treatment I’m last 2 weeks, systemic antibiotics in last 4 weeks, chemical peeling in last 3 months, systemic isotretinoin in last 6 months
Hypersensitive to quinolones
Photosensitive condition/drugs
Pregnant/Lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total lesion countTimepoint: 2 months
- Secondary Outcome Measures
Name Time Method Global assessment by patientTimepoint: 2 months